Cholestasis progression effects on long-term memory in bile duct ligation rats
Nasrin Hosseini1, Hojjatallah Alaei2, Mohammad Reza Zarrindast3, Mohammad Nasehi4, Maryam Radahmadi2
1 Department of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran
2 Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Cognitive Neuroscience, Institute for Cognitive Science Studies; Department of Neuroscience, School of Advanced Medical Technologies and Department of Pharmacology, School of Medicine; Department of Addiction Studies, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
4 Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Garmsar Branch, Garmsar, Iran
|Date of Submission||01-Sep-2013|
|Date of Acceptance||02-Nov-2013|
|Date of Web Publication||20-Oct-2014|
Institute for Cognitive Science Studies (ICSS), Tehran
Source of Support: None, Conflict of Interest: None
Background : There is evidence that cognitive functions are affected by some liver diseases such as cholestasis. Bile duct ligation induces cholestasis as a result of impaired liver function and cognition. This research investigates the effect of cholestasis progression on memory function in bile duct ligation rats.
Materials and Methods: Male Wistar rats were randomly divided into five groups, which include: control group for BDL-7, control group for BDL-21, sham group (underwent laparotomy without bile duct ligation), BDL-7 group (7 days after bile duct ligation), and BDL-21 group (21 days after bile duct ligation). Step-through passive avoidance test was employed to examine memory function. In all groups, short-term (7 days after foot shock) and long-term memories (21 days after foot shock) were assessed.
Results: Our results showed that liver function significantly decreased with cholestasis progression (P < 0.01). Also our findings indicated BDL-21 significantly impaired acquisition time (P < 0.05). Memory retrieval impaired 7 (P < 0.05) and 21 days (P < 0.001) after foot shock in BDL-7 and BDL-21 groups, respectively.
Conclusion: Based on these findings, liver function altered in cholestasis and memory (short-term and long-term memory) impaired with cholestasis progression in bile duct ligation rats. Further studies are needed to better insight the nature of progression of brain damage in cholestatic disease.
Keywords: Cholestasis, learning, memory, rat
|How to cite this article:|
Hosseini N, Alaei H, Zarrindast MR, Nasehi M, Radahmadi M. Cholestasis progression effects on long-term memory in bile duct ligation rats. Adv Biomed Res 2014;3:215
|How to cite this URL:|
Hosseini N, Alaei H, Zarrindast MR, Nasehi M, Radahmadi M. Cholestasis progression effects on long-term memory in bile duct ligation rats. Adv Biomed Res [serial online] 2014 [cited 2019 May 22];3:215. Available from: http://www.advbiores.net/text.asp?2014/3/1/215/143263
| Introduction|| |
Cholestasis is known as a severe manifestation of many liver diseases in humans and in rodents. , It has been shown that structural and functional impairment of the hepatobiliary systems  that cause a failure in bile secretion in hepatocytes or ductular cells or an impairment of bile flow and accumulation of bile salts in the body. ,,
Cholestasis may result in liver disease and other extra hepatic complications. It may affect many systems in the body such as cardiovascular,  renal,  and immune systems.  Also it is considered as one of the factors that can alter some of the brain functions.  Cognitive impairment is one of the complications in humans , and animal models of liver disease, too.  Children and adults with liver dysfunction such as biliary atresia showed deficits in their performance intelligence quotient, learning and memory, and visuospatial functions. ,, It has been reported that cholestatic rats were poorer in the Morris water maze task and passive avoidance test. ,, It has also been showed that the ability to discriminate between the novel object and the previously experienced sample object and memory were impaired in BDL rats  and in mice. 
Evidence suggests that the hippocampus is affected by cholestasis in rats. Besides, compelling evidence has confirmed the critical involvement of hippocampus upon memory processes in rats, monkeys, and humans. ,
Nevertheless, there has not been enough information regarding the cholestasis progression effects on cognitive function such as learning, memory and about stages of memory (short-term and long-term memory) may affect in BDL rats. In the present study, we examined the cognitive function in rats with cholestasis using the passive avoidance test.  The study was designed to evaluate the effects of cholestasis progression and its effects on acquisition and retention times of memory 7 and 21 days after BDL in rats
| Materials and methods|| |
Male Wistar rats (220-250 g) were obtained from Joundishapoor University (Ahvaz, Iran), central animal house, Iran. The animals were kept in animal house and provided with food and water ad libitum and they experienced a 12:12-h light-dark cycle (07:00 to 19:00) in a temperature-controlled environment (22 ± 2°C) and humidity of 40-70%. The animals were allowed to adapt to the laboratory conditions for at least 1 week before surgery. Each rat was handled for about 3 min each day prior to behavioral testing. All experiments were performed between 9:00 and 12:00 AM and each rat was tested only once. All experiments were conducted in accordance with the international guidance principles for biomedical research involving animals, revised in1985. We used six animals in each group.
Bile duct ligation surgery and induced cholestasis
There were five experimental groups with six rats in each group:
- Control-7 group (nonoperated, and kept in animal house for 7 days)
- Control-21 group (nonoperated, and kept in animal house for 21 days)
- Sham group (laparatomy surgery was performed without bile duct ligation)
- BDL-7 group; experiments were performed 7 days after bile duct ligation, and they were killed 21 days after BDL
- BDL-21 group; experiments were performed 28 days after BDL, and they were killed 42 days after BDL
Laparotomy was performed under general anesthesia, induced by injection of chloral hydrate (400 mg/kg, i.p). Sham group consisted of laparotomy and bile duct identification and manipulation without ligation or resection (with the aim of measuring possible stress induced by surgery). In the bile duct ligation groups, the main bile duct was first ligated using two ligatures approximately 0.5 cm apart and then transected at the midpoint between the two ligatures.  In the immediate postoperative period, each animal was placed in a cage by itself to prevent wound dehiscence and was moved to its original cage 4 h after the surgery. 
Memory testing and apparatus
The training apparatus had two compartments comprising a dark chamber (25 × 25 × 20 cm) and a light compartment (25 × 25 × 20 cm). They were separated by a guillotine door. Electric shocks were delivered to the grid floor by an isolated stimulator. At the beginning, each rat was placed in the apparatus for 5 min to habituate. On the second day, an acquisition trial was performed; rats were placed individually in the illuminated chamber. After a habituation period (1 min), the guillotine door was lifted. The latency to enter dark chamber was recorded as initial latency (IL). When the rat entered the dark chamber, the door was lowered and an inescapable scrambled single electric shock (0.2 mA, 50 HZ) was delivered for 3 s. In probe trial, the interval between placement in the illuminated chamber and entry into the dark chamber was measured and compared with own IL.
Twenty-one days after surgery, a sample of blood (3-4 ml) was collected then plasma bilirubin (total bilirubin, direct and indirect bilirubin) , levels were determined by using a commercially available kit (Zist Shimi, Tehran, Iran).
Repeated measure analysis of variance (ANOVA) was used for data analysis. Post-hoc analysis (Tukey-test) was performed for assessing specific inter-group variations. Differences with P < 0.05 between experimental groups at each point were considered statistically significant. The results are presented as the mean ± S.E.M.
| Results|| |
Induction of cholestasis
One day after bile duct ligation, the animals showed signs of cholestasis (jaundice, dark urine, and steatorrhea), which were tested qualitatively and quantitatively [Table 1]. BDL rats showed biochemical evidence of cholestasis with significant elevations in serum bilirubin and alanine amino transaminase levels.
Passive avoidance learning test
The latencies were measured in prefoot shock (IL), as well as 7 and 21 days postfoot shock (retention time or STL). Decrement of the latency (shorter time to enter the dark chamber after receiving foot shock) indicates that memory functions were impaired.
Repeated measure ANOVA and post-hoc Turkey's analysis revealed that there were not significant differences between controls and sham groups, thus surgery did not affect preshock latencies (IL) in experimental groups [Figure 1]a.
|Figure 1: Comparison of latency to enter the dark chamber before receiving foot shock (Initial latency). Each bar represents the mean ± S.E.M. Panel A- There were no significant differences between the control-7, control-21, and sham groups; Panel B- Differences between the Control-7 and BDL-7 groups were not significant, but there were significant differences between the control-21 and BDL-21 groups (٭P<0.05). Each group consisted of six rats|
Click here to view
Also, there were no significant differences in IL between control-7 and BDL-7 groups. In contrast, There were significant differences between control-21 and BDL-21 groups in IL (P < 0.05) and preshock latency to enter dark room was longer in BDL-21 group compared with control-21 group [Figure 1]b.
Our results showed that there were no significant differences between control-7, control-21, and sham groups in latency to enter dark chamber 7 days after receiving foot shock. So surgery has no effect on the results [Figure 2]a. A memory deficit was observed in BDL-7 (14 days after BDL) and BDL-21 (28 days after BDL) groups in latency to enter dark chamber 7 days after receiving foot shock. There were significant differences between BDL-7 and BDL-21 groups in 7 days after receiving foot shock compared with the corresponding controls groups (P < 0.05 and P < 0.01, respectively; [Figure 2]b.
Also, there were no differences among control-7, control-21, and sham groups in 21 days after receiving foot shock to enter the dark chamber [Figure 3]a.
Our results showed that there were significant differences between control-7 and BDL-7 groups in the latency to enter the dark chamber 21 days after receiving foot shock (28 days after BDL) compared with the corresponding controls groups (P < 0.001, [Figure 3]b.
|Figure 2: Comparison of latency to enter the dark chamber 7 days after receiving foot shock (short-term memory). Each bar represents the mean ± SEM. Panel A- There were no significant differences between the control-7, control-21, and sham groups. Panel B- The retention time was significantly decreased in the BDL-7 and BDL-21 groups when compared with the corresponding controls groups (٭P<0.05, ٭٭P<0.01). Each group consisted of six rats|
Click here to view
|Figure 3: Comparison of latency to enter the dark chamber 21 days after receiving foot shock (the long-term memory). Each bar represents the mean ± SEM. Panel-A; There were not significant differences between the control-7, control-21 and sham groups. Panel-B; The retention time was significantly decreased in the BDL-7 and BDL-21 groups when compared with the corresponding controls groups (٭٭٭P<0.001, ???P<0.001). Each group consisted of six rats|
Click here to view
There were no significant differences within control-7, control-21, and sham groups in 7 and 21 days after foot shock to enter dark chamber, although latencies to enter dark chamber after 7 and 21 days were significant in BDL-7 and BDL-21 groups [Figure 4].
|Figure 4: Time delay for entering into the dark room before and after 7 and 21 days receiving electrical foot shock; the reduction of the latency in the control-7, control-21, and sham groups was not significant during 7 and 21 days. Comparison of the latency 7 with 21 days in the BDL-7 and BDL-21 groups showed a significant decrease|
Click here to view
| Discussions|| |
The main findings of this study were that memory retrieval (short-term memory) impaired after 7 days of BDL, and it has worsened with cholestasis progression after 21 (BDL-7 group) and 42 days (BDL-21 group, long-term memory) after bile duct ligation rats [Figure 2]b, [Figure 3]b and [Figure 4]. Also IL did not alter in early stages of disease, but it impaired 21 days post-BDL [Figure 2]b. In the passive avoidance test after training, animals learn to avoid entering the dark chamber after receiving electrical foot shock.  Also our previous data (not presented here) showed that short-term memory (24 h after receiving foot shock) did not alter in early stage of cholestasis in BDL rats. Some articles reported that BDL causes biliary cirrhosis, fibrosis, portal hypertension, portal-systemic shunting, and immune system dysfunction. It has been shown that bile duct ligation after 3-4 weeks cause cirrhosis. ,,, Mild cognitive impairment reported in patients with the liver cirrhosis.  Furthermore, in some patients with liver disease and signs of hyperamonia it has been showed that impaired attention, memory, cognitive function, and motor function. ,
Our findings are consistent with some studies that reported an impaired spatial memory and ability to discriminate the novel object after BDL in rodents. ,, Of course the beginning time of disturbances has not been studied. Moreover, in the patients with liver disease have been reported deficits in attention, visual perception, and working memory. ,
The BDL is a model of chronic liver injury. It has been showed that both acute and chronic liver failure induces cholestasis that affects brain functions. ,, The molecular mechanisms by which liver failure impairs cognitive function remain unknown. Some studies suggested that in the liver disease hyperammonia is one of the main factors responsible for the neurological alterations.  Also it has been suggested that some mechanisms for glutamatergic system involvement in amnesia induced such as change of brain NO, oxidative stress, disruption of calcium homeostasis, membrane damage, and cell death. ,,,, All of the above-mentioned biologic effects can result in cognitive deficits in amnesia induced in BDL rats. Although the mechanisms of amnesia that were induced by cholestasis in BDL rats, have not been fully elaborated.
Previous studies indicated low locomotor performances in swimming  and treadmill running tests in BDL rats after 5 days.  Our previous data showed despite a decline in locomotor activity, this change was not significant 12 days post-BDL  and locomotor activity significantly decreased after 21 days in cholestatic rats (data not shown here). Probably parts of our results could be due to decreased motor function in cholestatic rats. Although, some of the studies proposed that fatigue is responsible for locomotor disturbances in BDL. The mechanisms involved in fatigue that accompanies with cholestasis may occur as a result of changes in the central nervous system as shown previously. , Among the neurotransmitter systems, serotonergic and adrenaline pathways are both implicated in fatigue states.  In the literature, it was shown that these systems are intimately involved in the control of central corticotropin-releasing hormone (CRH) release.  Not only the serotonergic system but also the opioidergic system was demonstrated to be affected in cholestasis. ,, Studies indicated that in BDL animals without obvious signs of infection, fever, or signs of sepsis showed activation of pro-inflammatory cytokines,  similar to those found in human with liver disease  that associated with activation of inflammatory mediators, provokes a greater behavioral impairment.
In summary, the results showed that chronic liver failure leads to developed cognitive impairments with progression of cholestasis in BDL rats.
| Acknowledgments|| |
The authors would like to thank Dr. Mehdi Nematbakhsh for his valuable assistance.
| References|| |
Roma M, Crocenzi F. Hepatocellular transport in acquired cholestasis: New insights into functional, regulatory and therapeutic aspects. Clin Sci 2008;114:567-88.
Sheen JM, Huang LT, Hsieh CS, Chen CC, Wang JY, Tain YL. Bile duct ligation in developing rats: Temporal progression of liver, kidney, and brain damage. J Pediatr Surg 2010;45:1650-8.
Aksu B, Umit H, Kanter M, Guzel A, Aktas C, Civelek S, et al
. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochem 2010;112:259-69.
Huang LT, Chen CC, Sheen JM, Chen YJ, Hsieh CS, Tain YL. The interaction between high ammonia diet and bile duct ligation in developing rats: Assessment by spatial memory and asymmetric dimethylarginine. Int J Dev Neurosci 2010;28:169-74.
Garcia-Ayllon M, Silveyra MX, Candela A, Compan A, Claria J, Jover R, et al
. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation. Hepatology 2006;43:444-53.
Zarrindast MR, Hoseindoost S, Nasehi M. Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice. Behav Brain Res 2012;228:116-24.
Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, Ebrahimi F, Shafaroodi H, Mirkhani SH, et al
. Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: The role of endogenous opioid peptides. J Hepatol 2005;43:491-8.
Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA. Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 2001;60:1047-57.
Swain MG. Cytokines and neuroendocrine dysregulation in obstructive cholestasis: Pathophysiological implications. J Hepatol 2001;35:416-8.
Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 2009;51:528-34.
Monfort P, Muñoz MD, ElAyadi A, Kosenko E, Felipo V. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis 2002;17:237-50.
Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al
. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-9.
Huang LT, Tiao MM, Tain YL, Chen CC, Hsieh CS. Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr Res 2009;65:176-80.
Ryan C, Than T, Blumgart L. Choledochoduodenostomy in the rat with obstructive jaundice. J Surg Res 1977;23:321-31.
Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier Jr RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-21.
Morris R, Garrud P, Rawlins J, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-3.
Hosseini N, Nasehi M, Radahmadi M, Zarrindast MR. Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats. Behav Brain Res 2013;256:636-45.
Garcia-Moreno L, Conejo N, González-Pardo H, Aller M, Nava M, Arias J, et al
. Evaluation of two experimental models of hepatic encephalopathy in rats. Braz J Med Biol Res 2005;38:127-32.
Cahill L, Weinberger NM, Roozendaal B, McGaugh JL. Is the amygdala a locus of "conditioned fear"? Some questions and caveats. Neuron 1999;23:227-8.
Rastegar H, Homayoun H, Afifi M, Rezayat M, Dehpour AR. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Eur Neuropsychopharmacol 2002;12:111-8.
Nasehi M, Sahebgharani M, Haeri-Rohani A, Zarrindast MR. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol Learn Mem 2009;92:391-9.
Gartung C, Ananthanarayanan M, Rahman M, Schuele S, Nundy S, Soroka C, et al
. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996;110:199-209.
Woodman D, Maile P. Bile acid assays as an index of cholestasis. Clin Chem 1981;27:846-8.
Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility-molecular mechanisms. Clin Liver Dis 2008;12:915-37.
Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305-11.
Michalak A, Knecht K, Butterworth RF. Hepatic encephalopathy in acute liver failure: Role of the glutamate system. Adv Exp Med Biol 1997;420:35-43.
Tarter RE, Arria AM, Carra J, Van Thiel DH. Memory impairments concomitant with nonalcoholic cirrhosis. Int J Neurosci 1987;32:853-9.
Nasehi M, Tackallou SH, Hasani I, Nasehi M. Cholestasis impaired spatial and non-spatial novelty detection in mice. Neurobiol Learn Mem 2013;4:2008-4978.
Aronson DC, Chamuleau RA, Frederiks WM, Gooszen HG, Heijmans HS, James J. Reversibility of cholestatic changes following experimental common bile duct obstruction: Fact or fantasy? J Hepatol 1993;18:85-95.
Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A, Dehpour AR. Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav Pharmacol 2013;24:195-206.
Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, et al
. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 2004;40:742-8.
Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003;39:320-5.
Jover R, Rodrigo R, Felipo V, Insausti R, Saez-Valero J, García-Ayllón M, et al
. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1257-66.
Cauli O, López-Larrubia P, Rodrigues TB, Cerdán S, Felipo V. Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors. J Neurochem 2007;103:1334-43.
Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 2003;15:84-9.
Nasehi M, Piri M, Abbolhasani K, Zarrindast MR. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice. Behav Pharmacol 2013;24:180-94.
Stewart SM, Campbell RA, McCallon D, Waller DA, Andrews WS. Cognitive patterns in school-age children with end-stage liver disease. J Dev Behav Pediatr 1992;13:331-8.
Keller JN, Guo Q, Holtsberg F, Bruce-Keller A, Mattson MP. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 1998;18:4439-50.
Keller JN, Mattson MP. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998;9:105-16.
Swain MG, Maric M. Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 1997;25:291-4.
Soares DD, Coimbra CC, Marubayashi U. Tryptophan-induced central fatigue in exercising rats is related to serotonin content in preoptic area. Neurosci Lett 2007;415:274-8.
Celik T, Goren MZ, Cýnar K, Gurdal H, Onder FO, Tan A, et al
. Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. Hepatology. 2005;41:731-7.
Burak KW, Le T, Swain MG. Increased midbrain 5-HT- 1A receptor number and responsiveness in cholestatic rats. Brain Res 2001;892:376-9.
Bearn J, Wessely S. Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest 1994;24:79-90.
Thornton J, Losowsky M. Opioid peptides and primary biliary cirrhosis. BMJ 1988;297:1501-4.
Bergasa NV, Jones EA. The pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids. Gastroenterology 1995;108:1582-8.
Terzioglu B, Aypak C, Yananlý HR, Kucukibrahimoglu E, Yurdaydýn C, Goren MZ. 5-hydroxytryptamine release in the anterior hypothalamic and the hippocampal areas of cholestatic rats. Life Sci 2006;78:1078-83.
Zietz B, Wengler I, Messmann H, Lock G, Schölmerich J, Straub RH. Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis. J Hepatol 2001;35:329-37.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]